GraphPad Software

Dotmatics Launches GraphPad Prism 10 with a More Open File Format, Plus New Collaboration and Integration Capabilities

Retrieved on: 
Wednesday, November 15, 2023
Cloud, Research, Organization, GraphPad Software, Meta-analysis, Data analysis, CSV, Master of Science, Teaching, FAIR, Interdisciplinarity, MD, Epidemiology, PNG, ANOVA, Doctor of Philosophy, JSON, AI, Dotmatics, Publication, Collaboration, Telescopic sight, Medical device, Prism

BOSTON, Nov. 15, 2023 /PRNewswire/ -- Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced a major new release of its popular GraphPad Prism application, the world's leading analysis and graphing solution for scientific research. Prism 10 introduces a number of features including a new, more open file format (.prism), a variety of core graphing and analysis improvements, and a beta for Prism Cloud. The enhanced functionality makes it easier for scientists using Prism to collaborate and integrate diverse data into their scientific workflows and applications. Learn more about the new capabilities at: https://www.graphpad.com/updates/prism-1000-release-notes.

Key Points: 
  • Prism 10 introduces a number of features including a new, more open file format (.prism), a variety of core graphing and analysis improvements, and a beta for Prism Cloud.
  • Prism is an advanced statistical analysis software designed to help scientists create graphs to visualize and analyze data.
  • In February, Dotmatics announced that its R&D platform was the very first to integrate directly with Prism.
  • The new, more open Prism file format helps organizations connect scientific workflows that allow for greater collaboration and interdisciplinary research.

Dotmatics Releases Powerful Enhancements to its Biology Solution to Help Accelerate the Research and Discovery of Life-Improving Therapies

Retrieved on: 
Wednesday, September 13, 2023
Product management, Enterprise, Dotmatics, High-performance Integrated Virtual Environment, ELN, Workflow, Research, GraphPad Software, Downstream processing, Science, Discovery, Data mining, Drug discovery, Fine chemical, Online shopping

BOSTON, Sept. 13, 2023 /PRNewswire/ -- Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the availability of the latest version of its Biology Solution, an end-to-end biologics data management and analysis tool designed to help R&D leaders get more insight from their data, faster. The Biology Solution offers common workflows for scientists who work in biopharma, industrial biotech, and AgTech to accelerate new product development, simplify project management, and reduce the complexities of research IT infrastructure. The new version includes expanded functionality for molecular cloning and vector design, protein production, new biologics registration, and more.

Key Points: 
  • The Biology Solution offers common workflows for scientists who work in biopharma, industrial biotech, and AgTech to accelerate new product development, simplify project management, and reduce the complexities of research IT infrastructure.
  • The Biology Solution is the latest update to a suite of recently released Dotmatics Solutions, which are pre-configured packages of capabilities and workflows to support specific scientific disciplines.
  • In addition, the Biology Solution reduces time to implementation, enhances the customer's drug discovery capabilities, and reduces internal data transfer requirements.
  • Enterprise includes access to Dotmatics' ELN and Data Discovery capabilities to support a broad array of biologics discovery.

Dotmatics Scientific R&D Platform Introduces Built-in GraphPad Prism Integrations

Retrieved on: 
Wednesday, February 8, 2023
Molecule, Organization, City, GPCR, City of Hope, Stanford University, Biology, GraphPad Software, Harvard University, Research, Senior, CDC, Merck, NASA, Science, Student, FAIR, Afton Chemical, Sanofi, Chemistry, Nobel Prize, Dotmatics, Medical device, Telescopic sight, Yale University, Prism

BOSTON, Feb. 8, 2023 /PRNewswire/ -- Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced integration between its scientific R&D platform and its GraphPad Prism product, the world's leading analysis and graphing solution for scientific research. Now, scientists and researchers can export assay data directly to Prism from the latest release of the Dotmatics' cloud-based platform, a critical step towards ensuring that all information shared meets FAIR data principles. Users can create Prism templates with preset analyses and graphs, making it easier to export data from Dotmatics ELN and screening tools using a standardized method. This integration provides scientists with an easy-to-use, reproducible, no-code method to create publication-quality graphs. Learn more at https://www.dotmatics.com/solutions/prism.

Key Points: 
  • "Dotmatics is the first and only R&D platform to offer integration with Prism, enabling scientific organizations to save time, accelerate research, and promote higher quality data.
  • With the integration, the scientist can export the individual experiment data, with or without a Prism template, directly into Prism.
  • Today, Dotmatics offers customers a core scientific platform comprised of tools such as an electronic lab notebook, data discovery, and screening.
  • For more than 25 years, Prism has provided comprehensive analysis and simplified powerful statistics exclusively for the international scientific community.

Dotmatics Launches Small Molecule Drug Discovery Solution Helping Researchers Accelerate Life-Improving Therapies

Retrieved on: 
Monday, July 18, 2022
Molecule, Cheminformatics, Research, LabArchives, Biology, Discovery, Patient, Database, Gaps, Solution, Pharmacy, View, Drug discovery, Insight Partners, Technology, Flow cytometry, Ownership, QC, Workflow, Chemistry, DMPK, GraphPad Software, Organization, CRO, Efficiency, Congressional Budget Office, FAIR, SAR, Data management, Fine chemical, Pharmaceutical industry, Dotmatics, Charles River Laboratories

The solution helps companies innovate more easily by leveraging best practices derived from the company's 15+ years of experience supporting small molecule drug discovery.

Key Points: 
  • The solution helps companies innovate more easily by leveraging best practices derived from the company's 15+ years of experience supporting small molecule drug discovery.
  • The Small Molecule Drug Discovery Solution promotes greater collaboration and productivity among research teams, reduces operational inefficiencies, and speeds the process of taking data from insights to decisions.
  • In May, Dotmatics introduced its Biology Solution for Antibody Discovery , which combines Dotmatics' enterprise scientific platform with advanced applications software used routinely in antibody discovery laboratories.
  • The Dotmatics Small Molecule Drug Discovery Solution incorporates FAIR data practices and provides a uniquely broad and deep solution from hit discovery through lead optimization to progress into animal trials and translational medicine.

Protein Metrics receives Several US Patents, Strengthening the Company's Intellectual Property Position

Retrieved on: 
Tuesday, June 21, 2022
Name, Insight Partners, GraphPad Software, Patent, Observation, CEO, Data compression, Efficiency, Biotechnology, San Francisco Bay Area, Mass spectrometry, Dotmatics, LabArchives, Software, Doctor of Philosophy, Thought, Organization, Fine chemical, Management

CUPERTINO, Calif., June 21, 2022 /PRNewswire-PRWeb/ -- Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software and part of the Dotmatics family of scientific R&D software, announced today the granting of three new US patents. The patent names and numbers are entitled: "Interactive analysis of mass spectrometry data (US #11,289,317)", "Data compression for multidimensional time series data US 11,276,204)", and "Intact mass reconstruction from peptide level data and facilitated comparison with experimental intact observation. (US 11,346,844 B2)"

Key Points: 
  • (US 11,346,844 B2)"
    This adds to the growing corpus of patents and underscores Protein Metrics' commitment to innovation and its position at the forefront of the field of protein analysis.
  • In December, Protein Metrics was acquired by Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making.
  • Protein Metrics supports hundreds of organizations worldwide with Byos and Byosphere Enterprise Platform for protein characterization.
  • Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at https://dotmatics.com .

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Retrieved on: 
Monday, June 6, 2022
Research, Technology, Chemicals, Plastics, Software, Manufacturing, Biotechnology, Pharmaceutical, Health, Data Management, Science, People, Board, Dropbox, Goal, International relations, HR, Google, COVID, General counsel, Research, Accenture, IPO, Corporation, CEO, Love, ARR, Organization, Solution, LabArchives, Technology, Data management, Columbia University, Insight Partners, Tufts University, Culture, Efficiency, Master, Boston University, GraphPad Software, Software as a service, Cancer, Master of International Affairs, Management, Cvent, Dotmatics

The appointments further bolster the companys executive team as the company extends the reach of its research and data solutions globally.

Key Points: 
  • The appointments further bolster the companys executive team as the company extends the reach of its research and data solutions globally.
  • Dotmatics is helping scientists to accelerate discoveries that make the world a healthier, cleaner and safer place to live.
  • We are adding Larry and Neil at a significant time in our companys growth, said Thomas Swalla, CEO of Dotmatics.
  • Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at https://dotmatics.com .

Dotmatics Biology Solution for Antibody Discovery Streamlines Data Collection and Workflows to Accelerate Antibody Research and Therapies

Retrieved on: 
Tuesday, May 3, 2022
Technology, Research, Clinical Trials, Software, Biotechnology, Health, Pharmaceutical, Data Management, Science, Insight Partners, Data management, Love, Chemistry, CLC bio, FAIR, Patient, Digital Solutions, LabArchives, Organization, Research report, Â, Workflow, Efficiency, Science, Conference, Research, Biology, Growth, GraphPad Software, Medical device, Fine chemical, Vaccine, Dotmatics

The antibody workflow combines Dotmatics enterprise scientific platform with advanced applications software used routinely in antibody discovery laboratories including Geneious , SnapGene , and GraphPad Prism .

Key Points: 
  • The antibody workflow combines Dotmatics enterprise scientific platform with advanced applications software used routinely in antibody discovery laboratories including Geneious , SnapGene , and GraphPad Prism .
  • The fully integrated solution will streamline data collection and processing of the antibody discovery workflow, facilitating a pathway to more effective and efficient discovery, and accelerating progress towards potentially life-changing therapies for patients.
  • The launch of the Dotmatics Biology Solution for Antibody Discovery is the industrys first true end-to-end solution for antibody workflows and represents a huge step forward for innovation in antibody discovery, said Mike McKee, president of Dotmatics.
  • Whether its R&D for biology or chemistry or formulations, Dotmatics helps scientists and their organizations harmonize data science with the science data.

Dotmatics, Previously Insightful Science, Set to Transform the Future of Scientific Software and Data Management

Retrieved on: 
Tuesday, April 26, 2022
Research, Technology, Genetics, Software, Biotechnology, Pharmaceutical, Health, Data Management, Science, Other Science, CEO, Decision-making, MIT, Research, Acceleration, Science, Organization, CFO, Patient, Merck, Growth, Infection, Conference, Debiopharm, GraphPad Software, Chemistry, Company, Solution, CRO, Biology, Safety, CMO, Industry, COVID, CIO, Pharmaceutical industry, Fine chemical, Mobile phone, Dotmatics

Scientific knowledge and growth in pharmaceutical drug discovery and chemicals & materials innovation is increasing at a faster pace than ever before.

Key Points: 
  • Scientific knowledge and growth in pharmaceutical drug discovery and chemicals & materials innovation is increasing at a faster pace than ever before.
  • COVID highlighted the need for rapid acceleration of scientific research and collaboration to lead to faster, more successful breakthroughs.
  • Yet the complexity of getting and using scientific data in meaningful ways has led to compromised success and delayed results among researchers and scientists.
  • We can transform scientific R&D with a platform that addresses the data challenges and then connects industry-favorite applications to better harmonize science and data.

Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

Retrieved on: 
Thursday, April 7, 2022
Technology, Research, Automotive, General Automotive, Software, Biotechnology, Health, Data Management, Science, Company, Adobe, Data management, Leadership, Insight Partners, Growth, CMO, Software as a service, CFO, Research, History, Science, CEO, Senior, ARR, Software, CRO, Instructure, Intel, Solution, IPO, GraphPad Software, Management, Fine chemical, Dotmatics

The appointments further strengthen the executive team as the Company continues to grow exponentially and scales the reach of its research and data solutions.

Key Points: 
  • The appointments further strengthen the executive team as the Company continues to grow exponentially and scales the reach of its research and data solutions.
  • Today, Insightful Science includes the Dotmatics enterprise platform and best-in-class applications for scientists including SnapGene , Geneious , and GraphPad Prism .
  • In 2021, Insightful Science deployed approximately $1 billion dollars of capital to acquire five leading scientific software applications that are critical in lab research.
  • Marta DeBellis has global expertise leading marketing for B2B SaaS businesses with annual recurring revenues (ARR) between 100s of millions to multi-billion.

Flow Cytometry Services Market Expected to Reach $ 1.5 Billion by 2030 - InsightAce Analytic Pvt. Ltd.

Retrieved on: 
Wednesday, March 2, 2022
Investment, Multiple myeloma, Government, LLC, KCAS, Acquisition, HIV, Cell, Diagnosis, Flow cytometry, Leukemia, NeoGenomics, Awareness, Solution, Drug development, US, Company, Cancer, Lymphoma, Transport, Becton, Infection, Becton, Dickinson and Company headquarters, BD, Science, GraphPad Software, Efficiency, Laboratory, Research, LabArchives, Charles River Laboratories, Bio-Rad Laboratories, Data analysis, Protein, CAGR, Glossary of biology, AIDS, Antibody, Fine chemical, Medical imaging, Unilab, Fluorescence

According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.

Key Points: 
  • According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.
  • Flow cytometry is an effective laboratory technique used to analyze the cell population in heterogenous suspension based on their physical and fluorescence characteristics.
  • Flow Cytometry services consist of specimen processing, experimental design, acquisition and data analysis to strengthen biotech, pharmaceutical companies and researchers in drug development.
  • Curious about Report Details @ Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-flow-cytometry-services...
    Global Flow Cytometry Services Market, by Accreditation Types, 2019-2030 (Value US$ Mn)
    Global Flow Cytometry Services Market, by Services Types, 2019-2030 (Value US$ Mn)